ROCM Financial Facts

Research and development: 320K
Marketing and selling: 4.29M
See Full Income Statement

Deferred income tax asset: 1.49M
Less accumulated depreciation: -20.65M
See Full Balance Sheet

Rochester Medical Corp. (ROCM) Earnings

  |   Expand Research on ROCM
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +4.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +3.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/30/13 Q313 $0.12$0.13 -$0.01$17M$16.75M N/A Details
4/25/13 Q213 $0.10$0.13 -$0.03$16.6M$16.54M N/A Details
1/29/13 Q113 $0.11$0.10 +$0.01$17.25M$15.86M N/A Details
11/13/12 Q312 $0.11$0.08 +$0.03$16.73M$17.84M N/A Details
7/26/12 Q212 $0.07$0.04 +$0.03$15.25M$16.93M N/A Details
4/24/12 Q112 $0.05$0.03 +$0.02$15.26M$15.46M N/A Details
1/25/12 Q112 $0.02$0.03 -$0.01$13.85M$14.9M N/A Details
11/3/11 Q411 $0.07N/A N/A $14.84M$11.12M N/A Details